The latest satisfaction survey results from Quilaban confirm the trust placed in the company by […]
Genetic disorders are among the leading causes of admission to neonatal and paediatric intensive care […]
We proudly celebrate 5 years of partnership between Quilaban and Illumina, a global leader in […]
Trisomy 21 and NIPT
